Searched for
MULTINATIONAL PHARMA COMPANIES
India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...- Healthium Medtech CEO Anish Bafna steps down, moves to non-executive chairman roleHealthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...
- Pharma in her DNA, Wockhardt scion ready for deep dive in the USZahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacteria...
- From ₹5,000 salary to ₹48 crore turnover: Meet Nayana Vaidya, a pharma saleswoman, who built a healthcare distribution company from scratchNayana Vaidya built Om Sai Surgicals from a modest beginning. Her company achieved a turnover of nearly ₹48 crore. Vaidya finds satisfactio...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Aurobindo Pharma approves Rs 800 crore share buyback. Check record date, other key detailsAurobindo Pharma is launching its first share buyback in two years, offering to repurchase over 54 lakh shares at Rs 1,475 each. This tende...
- India's pharma lobby bats for drug approvals in line with global marketsAccording to the OPPI, launching a new drug in India is delayed by up to four years, compared to markets like the US and the European Union...
- Drug launches, new permissions should be made public, say pharma MNCsIn a recent meeting held by the drug controller on global clinical trials, the OPPI sought from the government a notification system throug...
- Drug cos against move to rationalise trade margins on patented productsThe representatives of Organisation of Pharmaceutical Producers of India (OPPI), which represents multinational pharma companies and domest...
- Amit Rajan on why pharma MNCs are beating Indian counterpartsPatent protection, ban on fixed dose combinations among factors helping pharma MNCs
- UP to open 6 pharma parks; gets Rs 5,000-6,000 cr commitmentThe UP government is planning to open six pharma parks across the state and has received an investment commitment of about Rs 5,000-6,000 c...
- Mankind Pharma to open manufacturing plant in US, invest Rs 300 crore"We wish to become a multinational pharma company by tapping the foreign markets," Chairman and Founder RC Juneja said.
- Dilip Shanghvi, second-wealthiest Indian, is the poorest pharma CEOShanghvi’s salary for 2013-14 was Rs 2.73 crore, according to data sifted by ET from filings of leading listed drug companies.
- Only 3% of patents filed by MNC pharma firms under dispute: StudyPatent experts say few drugmakers are challenging frivolous drug patents and the Indian patent office is actually liberal in granting paten...
- India eyes $40 billion global generic market; patents held by MNCs to expire in over 3 yearsAnalysts say the timing to promote Indian generics globally is just right as the next three years will be crucial in terms of opportunity.
- GSK Pharma: Investors must be careful of the competitive threats it faces in IndiaWhile the company's performance in the June quarter was strong sequentially, it will be interesting to see GSK's strategies to overcome the...
- Price control of patented drugs may hit MNCs like Pfizer, GlaxoSmithKline hard: AnalystsThe government's decision to cap prices of patented drugs may hit the multinational pharma companies like Pfizer, GlaxoSmithKline and Merck...
- FDI curbs in pharma could deter MNCs: Kewal Handa, Pfizer India MDIndia's attempts to check foreign investment in pharma and expand drug pricing control could force multinationals to exit the country.
- Ipca, Indoco Remedies attractive in pharma space: Sudip BandyopadhyayCompanies like Ipca and Indoco Remedies are very attractively priced today.
- Let pharma takeovers beSale of Indian drug companies to multinationals is a way of value creation for Indian entrepreneurs and investors.
Load More
